Evaluation of Eli Lillys' Obesity Pipeline including Eloralintide and Retatrutide for Chronic Obesity

Executed on:Jan 29, 2026 4:00 PM EDT

Call Duration:30 minutes

Expert Profile

ExpertBlinded Expert

Institution: University of Chicago MedicineAssociate Professor of Medicine for Division of Endocrinology, Diabetes & Metabolism at the University of Chicago
Manages 12 patients monthly and has practiced for patients with weight management for the last 14 years 
Research focus is on investigating causes and treatments for obesity and associated metabolic dysfunction and Studying how chronic partial sleep loss, poor sleep quality, and sleep patterns relate to obesity, insulin resistance, inflammation, diabetes, and quality of life.

Interview Goal

This conversation will focus on the landscape of obesity  along with  the potential of Eli Lillys' Eloralintide and Triple Agonist Retatrutide.

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.